FDA launches COVID-19 adverse event reporting dashboard

March 17, 2021

The U.S. Food and Drug Administration (FDA) has launched the COVID-19 EUA FDA Adverse Events Reporting System Public Dashboard, which will provide the public with weekly updates on adverse events for drugs and therapeutic biological products used under emergency use authorization (EUA), the agency said in a news release.

The FAERS Public Dashboard is a web-based tool that allows users to query the database for information related to human adverse events reported to the FDA by the pharmaceutical industry, healthcare providers and consumers.

“The FDA anticipates that this increased transparency will help to spur the submission of more detailed and complete reports from consumers, healthcare providers and other members of the public. Complete and detailed reports are immensely helpful to the agency when identifying safety signals and choosing particular products for further scrutiny,” the agency said.

Visit the FDA for more news

Photo 111134338 © Kwanchaidt | Dreamstime.com
Photo 81363766 © Andrii Kucher | Dreamstime.com
Photo 125378010 © Komgrit Pradissagul | Dreamstime.com
Photo 36810879 © Tyler Olson | Dreamstime.com